packageBaricitinib

baricitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Baricitinib is a JAK inhibitor used to treat rheumatoid arthritis and, in some settings, COVID-19. It is an approved medicine and is authorised in the European Union for rheumatoid arthritis.

Summary written by glm-5.3-flash from Wikidata Q4860707 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:baricitinib
ATC codes:L04AA37, L04AF02
DrugBank:DB11817
PubChem CID:44205240
ChEBI:95341
Wikidata:Q4860707
formula:C16H17N7O2S
molar mass:371.419 g/mol (PubChem CID 44205240)
logP:-0.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown